{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:11:03Z","timestamp":1789873863048,"version":"4.0.1"},"publisher-location":"Chichester, UK","reference-count":53,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000215.pub3","type":"reference-entry","created":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T07:38:50Z","timestamp":1263800330000},"source":"Crossref","is-referenced-by-count":39,"title":["Anthelmintics for people with neurocysticercosis"],"prefix":"10.1002","author":[{"given":"Katharine","family":"Abba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridharan","family":"Ramaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Narasimhan","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD000215.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archneur.1989.00520470099034","article-title":"Neurocysticercosis: short course of treatment with albendazole","volume":"46","author":"Alarcon","year":"1989","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD000215.pub3-BIB2|cit2","first-page":"1","article-title":"Short course of albendazole therapy for neurocysticercosis: a prospective randomized trial comparing three days, eight days and the control group without albendazole","volume":"10","author":"Alarcon","year":"2001","journal-title":"Revista Ecuatoriana De Neurologia"},{"issue":"8","key":"10.1002\/14651858.CD000215.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006454-199808000-00007","article-title":"Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo controlled, double-blind trial","volume":"17","author":"Baranwal","year":"1998","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD000215.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/tropej\/48.4.219","article-title":"Morphometry of single small enhancing computed tomographic lesions: outcome and effect of albendazole therapy","volume":"48","author":"Baranwal","year":"2002","journal-title":"Journal of Tropical Pediatrics"},{"key":"10.1002\/14651858.CD000215.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2310\/7010.2001.7057","article-title":"Seizure recurrence and single small enhancing computed tomographic lesions: prognostic factors on long-term follow-up","volume":"6","author":"Baranwal","year":"2001","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD000215.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp.2008.144899","article-title":"Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial","volume":"79","author":"Carpio","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD000215.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0022-510X(95)00181-Z","article-title":"Neurocysticercosis: optimal dose treatment with albendazole","volume":"133","author":"Cruz","year":"1995","journal-title":"Journal of Neurological Sciences"},{"issue":"12","key":"10.1002\/14651858.CD000215.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jocn.2006.09.004","article-title":"Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study","volume":"14","author":"Das","year":"2007","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD000215.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jns.2008.09.010","article-title":"Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: effect on long-term seizure outcome","volume":"276","author":"Souza","year":"2009","journal-title":"Journal of the Neurological Sciences"},{"issue":"52","key":"10.1002\/14651858.CD000215.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/WNL.52.5.1079","article-title":"Single-day praziquantel versus 1-week albendazole for neurocysticercosis","volume":"23","author":"Brutto","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000215.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/infdis\/175.2.486","article-title":"Serologic evolution of neurocysticercosis patients after antiparasitic therapy","volume":"175","author":"Garcia","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD000215.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1212\/WNL.48.5.1421","article-title":"Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis working group in Peru","volume":"48","author":"Garcia","year":"1997","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000215.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0035-9203(03)90075-7","article-title":"Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo controlled trial in newly diagnosed cases","volume":"97","author":"Gogia","year":"2003","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.wnl.0000195887.63124.dc","article-title":"Albendazole trials at 15 or 30 mg\/kg\/day for subarachnoid and intraventricular cysticercosis","volume":"66","author":"Gongora-Rivera","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD000215.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(03)00211-7","article-title":"Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomised controlled trial","volume":"143","author":"Kalra","year":"2003","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD000215.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/INF.0b013e31819073aa","article-title":"Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis","volume":"28","author":"Kaur","year":"2009","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD000215.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.44.7.1344","article-title":"Albendazole in single CT ring lesions in epilepsy","volume":"44","author":"Padma","year":"1994","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD000215.pub3-BIB19|cit19","first-page":"255","article-title":"Albendazole in neurocysticercosis","volume":"8","author":"Padma","year":"1995","journal-title":"National Medical Journal of India"},{"issue":"4","key":"10.1002\/14651858.CD000215.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/088307380001500401","article-title":"Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy","volume":"15","author":"Singhi","year":"2000","journal-title":"Journal of Child Neurology"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.inf.0000055095.84136.a2","article-title":"One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo controlled double-blind trial","volume":"22","author":"Singhi","year":"2003","journal-title":"Pediatric Infectious Diseases Journal"},{"issue":"5","key":"10.1002\/14651858.CD000215.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/088307380401900503","article-title":"Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis","volume":"19","author":"Singhi","year":"2004","journal-title":"Journal of Child Neurology"},{"issue":"5","key":"10.1002\/14651858.CD000215.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archneur.1988.00520290064015","article-title":"Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial","volume":"45","author":"Sotelo","year":"1988","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD000215.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00314663","article-title":"Comparison of therapeutic regimen of anticystercal drugs for parenchymal brain cysticercosis","volume":"237","author":"Sotelo","year":"1990","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD000215.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1590\/S0004-282X1991000100007","article-title":"Neurocysticercosis in childhood: II computed tomography of 24 patients according to symptomatic treatment and with praziquantel","volume":"49","author":"Antoniuk","year":"1991","journal-title":"Arquivos de Neuro-Psiquiatria"},{"key":"10.1002\/14651858.CD000215.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.clineuro.2004.12.013","article-title":"Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst","volume":"108","author":"Bustos","year":"2006","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"18","key":"10.1002\/14651858.CD000215.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1001\/archinte.1995.00430180088010","article-title":"Is the course of neurocysticercosis modified by treatment with antihelminthic agents?","volume":"155","author":"Carpio","year":"1995","journal-title":"Archives of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD000215.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1212\/WNL.57.10.1929","article-title":"Optimization of the single-day praziquantel therapy for neurocysticercosis","volume":"57","author":"Lopez-Gomez","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000215.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/jnnp.2003.023572","article-title":"Pre-treatment with corticosteroids and a single cycle of high dose albendazole for subarachnoidal cysticercosis","volume":"75","author":"Marquez-Caraveo","year":"2004","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000215.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1528-1157.1993.tb02128.x","article-title":"Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial","volume":"34","author":"Medina","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD000215.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJMoa010212","article-title":"Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts","volume":"345","author":"Proano","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000215.pub3-BIB32|cit32","first-page":"116","article-title":"Albendazole therapy for neurocysticercosis","volume":"42","author":"Sanchetee","year":"1994","journal-title":"Journal of the Association of Physicians in India"},{"key":"10.1002\/14651858.CD000215.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp.2007.128058","article-title":"Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy","volume":"79","author":"Thussu","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000215.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0035-9203(91)90041-V","article-title":"Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation","volume":"85","author":"Cruz","year":"1991","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD000215.pub3-BIB35|cit35","first-page":"279","article-title":"Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis","volume":"22","author":"Cruz","year":"1991","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"4","key":"10.1002\/14651858.CD000215.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0303-8467(00)00110-4","article-title":"Short regimen of praziquantel in the treatment of single brain enhancing lesions","volume":"102","author":"Pretell","year":"2000","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archneur.1992.00530270106026","article-title":"Therapy for neurocysticercosis: comparison between albendazole and praziquantel","volume":"49","author":"Takayanagui","year":"1992","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD000215.pub3-BIB38|cit38","unstructured":"Randomized study of albendazole in patients with epilepsy due to neurocysticercosis Ongoing study"},{"key":"10.1002\/14651858.CD000215.pub3-BIB39|cit39","unstructured":"Burneo G Neurocysticercosis http:www\/eMedicine.com\/neuro\/topic629.htm (accessed 22 May 2006) 2005"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1535-7597.2004.43008.x","article-title":"Neurocysticercosis","volume":"4","author":"Giorgio","year":"2004","journal-title":"Epilepsy Currents"},{"issue":"1","key":"10.1002\/14651858.CD000215.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7326\/0003-4819-145-1-200607040-00009","article-title":"Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel","volume":"145","author":"Brutto","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000215.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.15.4.747-756.2002","article-title":"Current consensus guidelines for treatment of neurocysticercosis","volume":"15","author":"Garcia","year":"2002","journal-title":"Clinical Microbiology Reviews"},{"issue":"7303","key":"10.1002\/14651858.CD000215.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000215.pub3-BIB44|cit44","unstructured":"Kossoff EH Neurocysticercosis http:\/www.emedicine.com\/ped\/topic1573.htm>eMedicine (accessed February 2006) 2005"},{"key":"10.1002\/14651858.CD000215.pub3-BIB45|cit45","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD000215.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/WNL.55.10.1485","article-title":"Calcified neurocysticercosis lesions and postsurgery seizure control in temporal lobe epilepsy","volume":"55","author":"Leite","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000215.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0883073807300295","article-title":"Does albendazole affect seizure remission and computed tomography response in children with neurocysticercosis? A systematic review and meta-analysis","volume":"22","author":"Mazumdar","year":"2007","journal-title":"Journal of Child Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000215.pub3-BIB48|cit48","first-page":"141","article-title":"Seizures associated with solitary cystericus granuloma: antiepileptic drugs for so long?","volume":"54","author":"Murthy","year":"2006","journal-title":"Neurology India"},{"issue":"1","key":"10.1002\/14651858.CD000215.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0028-3886.30425","article-title":"Economic evaluation of seizures associated with solitary cysticercus granuloma","volume":"55","author":"Murthy","year":"2007","journal-title":"Neurology India"},{"key":"10.1002\/14651858.CD000215.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4067\/S0034-98872006000600017","article-title":"Treatment of neurocysticercosis: a review","volume":"134","author":"Nogales-Gaete","year":"2006","journal-title":"Revista M\u00e9dica de Chile"},{"key":"10.1002\/14651858.CD000215.pub3-BIB51|cit51","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"3","key":"10.1002\/14651858.CD000215.pub3-BIB52|cit52","first-page":"399","article-title":"A proposal to declare neurocysticercosis an international reportable disease","volume":"78","author":"Roman","year":"2000","journal-title":"Bulletin of the World Health Organization"},{"issue":"4","key":"10.1002\/14651858.CD000215.pub3-BIB53|cit53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000215.pub2","article-title":"Drugs for treating neurocysticercosis (tapeworm infection of the brain)","author":"Salinas","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000215.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T16:55:30Z","timestamp":1628528130000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000215.pub3"}},"subtitle":[],"editor":[{"given":"Katharine","family":"Abba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":53,"aliases":["10.1002\/14651858.cd000215.pub4"],"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000215.pub3","relation":{},"subject":[],"published":{"date-parts":[[2010,1,20]]}}}